These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8728328)

  • 1. High level secretion of wild-type and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression.
    Sorci-Thomas MG; Parks JS; Kearns MW; Pate GN; Zhang C; Thomas MJ
    J Lipid Res; 1996 Mar; 37(3):673-83. PubMed ID: 8728328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein.
    Huang W; Matsunaga A; Li W; Han H; Hoang A; Kugi M; Koga T; Sviridov D; Fidge N; Sasaki J
    Atherosclerosis; 2001 Nov; 159(1):85-91. PubMed ID: 11689210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of prebeta-high density lipoprotein to alpha-high density lipoprotein.
    Sviridov D; Pyle LE; Jauhiainen M; Ehnholm C; Fidge NH
    J Lipid Res; 2000 Nov; 41(11):1872-82. PubMed ID: 11060357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High yield overexpression and characterization of human recombinant proapolipoprotein A-I.
    McGuire KA; Davidson WS; Jonas A
    J Lipid Res; 1996 Jul; 37(7):1519-28. PubMed ID: 8827524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction.
    Huang W; Sasaki J; Matsunaga A; Han H; Li W; Koga T; Kugi M; Ando S; Arakawa K
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):210-6. PubMed ID: 10634820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional properties of full-length and truncated human proapolipoprotein AI expressed in escherichia coli.
    Pyle LE; Sawyer WH; Fujiwara Y; Mitchell A; Fidge NH
    Biochemistry; 1996 Sep; 35(37):12046-52. PubMed ID: 8810909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
    Laccotripe M; Makrides SC; Jonas A; Zannis VI
    J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements.
    Cho KH; Durbin DM; Jonas A
    J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of biologically active human proapolipoprotein A-I in a baculovirus-insect cell system: protection from degradation by protease inhibitors.
    Pyle LE; Barton P; Fujiwara Y; Mitchell A; Fidge N
    J Lipid Res; 1995 Nov; 36(11):2355-61. PubMed ID: 8656073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT.
    Forte TM; Bielicki JK; Goth-Goldstein R; Selmek J; McCall MR
    J Lipid Res; 1995 Jan; 36(1):148-57. PubMed ID: 7706940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants.
    Jonas A; von Eckardstein A; Kézdy KE; Steinmetz A; Assmann G
    J Lipid Res; 1991 Jan; 32(1):97-106. PubMed ID: 1901346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human apolipoprotein A-I isoprotein metabolism: proapoA-I conversion to mature apoA-I.
    Bojanovski D; Gregg RE; Ghiselli G; Schaefer EJ; Light JA; Brewer HB
    J Lipid Res; 1985 Feb; 26(2):185-93. PubMed ID: 3989377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Arg123-Tyr166 paired helix of apolipoprotein A-I in lecithin:cholesterol acyltransferase activation.
    Dhoest A; Zhao Z; De Geest B; Deridder E; Sillen A; Engelborghs Y; Collen D; Holvoet P
    J Biol Chem; 1997 Jun; 272(25):15967-72. PubMed ID: 9188498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding.
    Minnich A; Collet X; Roghani A; Cladaras C; Hamilton RL; Fielding CJ; Zannis VI
    J Biol Chem; 1992 Aug; 267(23):16553-60. PubMed ID: 1644835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
    Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
    Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the propeptide of apolipoprotein A-I impairs exit of nascent apolipoprotein A-I from the endoplasmic reticulum.
    McLeod RS; Robbins C; Burns A; Yao Z; Pritchard PH
    Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):641-8. PubMed ID: 7945187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of apolipoprotein A-I in three homogeneous, reconstituted high density lipoprotein particles.
    Wald JH; Krul ES; Jonas A
    J Biol Chem; 1990 Nov; 265(32):20037-43. PubMed ID: 2123198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase.
    Durbin DM; Jonas A
    J Lipid Res; 1999 Dec; 40(12):2293-302. PubMed ID: 10588955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins.
    Jin L; Shieh JJ; Grabbe E; Adimoolam S; Durbin D; Jonas A
    Biochemistry; 1999 Nov; 38(47):15659-65. PubMed ID: 10569952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.